Familial pulmonary fibrosis accounts for a considerable number of interstitial lung disease cases, a new study shows.

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...

GLASGOW, Scotland — The antifibrotic medication nerandomilast works in people with rheumatic disease and progressive pulmonary fibrosis (PPF) just as well as it does in the general population of ...

Emerging Therapeutic Directions for Cancers With Mutations Within the Complex Proteins Associated With Set1 Family: A Systemic Review Interstitial lung disease (ILD) and pneumonitis have both been ...

Delayed diagnosis of fibrotic ILD leads to higher mortality rates and shorter overall survival, emphasizing the need for early clinical recognition. Supplemental oxygen therapy in fibrotic ILD ...

Please provide your email address to receive an email when new articles are posted on . Persistently elevated ESR and CRP in patients with RA were associated with greater risk for interstitial lung ...

ILD patients show higher prevalence of fatigue (40.7%) and EDS (35.2%) compared to healthy controls, impacting quality of life. Fatigue in ILD patients correlates with exertional dyspnea, reduced ...